George Tidmarsh and Vinay Prasad have taken leadership roles at CDER and CBER, respectively, impacting FDA's drug and ...

The idea that a chatbot could be blamed for a killing has moved from science fiction into a courtroom, where lawyers are now ...

Discovering effective drug combinations may now be easier thanks to a screening platform made public today by St. Jude ...

The FDA has qualified AI-Based Histologic Measurement of NASH, or AIM-NASH — the first AI drug development tool — to assist ...

Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisitionAcquisition expected to resolve Nasdaq minimum ...

More on AI: When it comes to folding AI tools into mammograms, AI firms believe there’s even more knowledge to be gleaned ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of ...

The FDA’s implementation of AI tools marks the next step in the agency’s digital transformation efforts. Lets take a closer ...

For those who want to see a doctor, supported by AI or not, opting for care at outpatient facilities or telehealth options ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...

Holiday shoppers are increasingly relying on AI for gift decisions, with Salesforce estimating AI will influence $263B in ...

AI healthcare investment has already reached $10.7B in 2025, exceeding the entire 2024 total by 24% with nine months still remaining, as pharmaceutical companies race to compress ...